Scientists have detected exomoon formation in acetylene-rich zones around massive exoplanets using advanced spectroscopy, revealing how these hydrocarbon-rich environments provide building blocks for moons and potential complex chemistry.
Artificial intelligence is revolutionizing early drug discovery through AI-augmented molecular design, accelerating lead optimization, predicting molecular properties, and enabling generative models to propose novel compounds in data-scarce environments. Platforms like DeepChem and ChemAI foster collaboration, bridging chemistry, biology, and computational science for faster, more efficient drug development.
Artificial intelligence is revolutionizing drug discovery in 2026 by analyzing vast biological data to speed up identification of drug candidates, reducing development time from over a decade to about five years. Key players like Atomwise, BenevolentAI, Pfizer, and Roche leverage AI for target identification, personalized medicine, and optimized clinical trials, with regulators adapting guidelines to support these innovations.
It’s always good to remember where we’ve come from. Nostalgia helps us do that, but just because we yearn for the past doesn’t mean that things were always better back then. The beauty of these gadgets is that we can admire what’s come before while still living in the present.